Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-03-11$25.50/sh−10,000$255,000→ 331,227 total(indirect: By Trust)
Holdings
- 16,629
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.